GLP‑1 Weight Loss Program
Lose up to 20% of your body weight with physician‑guided GLP‑1 therapy featuring Zepbound® and Wegovy® — combined with nutrition coaching and ongoing support.
Why Choose Our GLP‑1 Program?
We prescribe FDA‑approved Zepbound® and Wegovy® — the most effective GLP‑1 medications available — with full medical oversight.
Clinically Proven Results
Zepbound® and Wegovy® have demonstrated average weight loss of 15–20% of body weight in clinical trials, with many patients seeing results within the first few months.
Reduced Appetite & Cravings
GLP‑1 medications work with your body’s natural hunger signals to reduce appetite and cravings, making it easier to stick to a healthy nutrition plan.
Physician‑Guided Care
Our licensed physicians prescribe, monitor, and adjust your Zepbound® or Wegovy® treatment to ensure safe and effective results throughout your journey.
Medications We Prescribe
We offer two FDA‑approved GLP‑1 medications, each backed by extensive clinical research.
Zepbound® (tirzepatide)
A dual GIP/GLP‑1 receptor agonist that targets two key hormones involved in appetite and metabolism. In clinical trials, patients on Zepbound® lost up to 22.5% of their body weight. Administered as a once‑weekly injection with gradual dose escalation.
Wegovy® (semaglutide)
A GLP‑1 receptor agonist that helps regulate appetite and calorie intake. In clinical trials, patients on Wegovy® lost an average of 15% of their body weight. Administered as a once‑weekly injection with gradual dose escalation.
How It Works
Four simple steps to get started with your GLP‑1 weight loss program.
Free Consultation
Discuss your goals, medical history, and preferences with our care team to determine if Zepbound® or Wegovy® is the right fit for you.
Medical Evaluation
A comprehensive evaluation including lab work as needed to confirm eligibility and choose the safest, most effective medication and starting dose.
Begin Treatment
Start your Zepbound® or Wegovy® prescription with personalized nutrition guidance and lifestyle support from day one.
Ongoing Support
Regular check‑ins, dose adjustments, side‑effect management, and progress tracking to keep you on course.
Zepbound® vs. Wegovy®
Both are effective — our physicians help you choose the best option for your needs.
| Zepbound® | Wegovy® | |
|---|---|---|
| Generic Name | Tirzepatide | Semaglutide |
| Mechanism | Dual GIP/GLP‑1 | GLP‑1 |
| Average Weight Loss | Up to 22.5% | Up to 15% |
| Administration | Once‑weekly injection | Once‑weekly injection |
| FDA Approved for Weight Loss | ✓ | ✓ |
Eligibility & Safety
Your safety is our priority. We carefully evaluate candidacy and monitor your progress throughout treatment.
Who It’s For
Adults with a BMI of 30 or higher, or a BMI of 27+ with weight‑related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol. Candidates should be ready to commit to nutrition and lifestyle changes alongside medication.
Safety & Monitoring
Full medical evaluation and lab work before starting. Ongoing monitoring for side effects such as nausea or digestive changes, with dose adjustments as needed. Zepbound® and Wegovy® are not suitable for all patients — our physicians will discuss alternatives if needed.
Frequently Asked Questions
Common questions about our GLP‑1 program.
Zepbound® (tirzepatide) is a dual GIP/GLP‑1 receptor agonist that targets two hormones, while Wegovy® (semaglutide) targets one. Both are FDA‑approved for weight loss. In clinical trials, Zepbound® showed higher average weight loss, but the best medication for you depends on your individual health profile.
Most patients begin to notice reduced appetite and early weight loss within the first 4‑8 weeks. Significant results typically develop over 3‑6 months as the dose is gradually increased to the target level.
Both Zepbound® and Wegovy® are FDA‑approved and backed by extensive clinical trials. Common side effects include mild nausea and digestive changes, which typically improve over time. Our physicians monitor you closely and adjust treatment as needed.
Treatment duration varies by individual. Many patients use GLP‑1 medications for 12 months or longer. Our physicians will work with you to develop a long‑term plan that supports sustained weight loss.
Coverage varies by insurance plan. Our team can help you understand your options, including manufacturer savings programs. We also offer competitive self‑pay pricing.
Ready to Start Your GLP‑1 Journey?
Schedule your free consultation to find out if Zepbound® or Wegovy® is right for you.